Copyright
©The Author(s) 2019.
World J Stem Cells. Aug 26, 2019; 11(8): 519-534
Published online Aug 26, 2019. doi: 10.4252/wjsc.v11.i8.519
Published online Aug 26, 2019. doi: 10.4252/wjsc.v11.i8.519
Figure 2 Therapeutic strategies in colorectal cancer.
Targeting the tumor bulk in colorectal cancer with adjuvant therapy leads to tumor regression, although CSCs may escape cell death. Such a chemoresistance event leads to tumor recurrence and overall poor prognosis. In contrast, treatment with a combination of adjuvant therapy and CSC-targeting therapy would also eradicate the CSC population, along with the tumor bulk. In the long term, reduction in CSC volume would kill the tumor. CSC: Cancer stem cells; ISC: Intestinal stem cells.
- Citation: Iyer DN, Sin WY, Ng L. Linking stemness with colorectal cancer initiation, progression, and therapy. World J Stem Cells 2019; 11(8): 519-534
- URL: https://www.wjgnet.com/1948-0210/full/v11/i8/519.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v11.i8.519